In another example, a US-managed care provider is using UiPath to tackle a backlog of more than 140,000 provider appeals.

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak ...

UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced financial results for its third quarter fiscal 2026 ended October 31, 2025.

UiPath is deepening its role inside enterprise workflows, and institutional capital is noticing. This breakdown highlights ...

If you have been wondering whether UiPath is a hidden bargain or a value trap at around $14.86 a share, you are not alone. This article is going to walk through exactly what the numbers are really ...

UiPath presents a compelling accumulation opportunity after recent profit-taking, with core RPA business strength and visible AI-driven growth catalysts. PATH's revenue growth has stabilized at double ...

Discover UiPath's Q3 2026 earnings: first GAAP profit, AI-driven automation gains, raised outlook, and key growth insights.

Shares of UiPath rose after the company swung to a third-quarter profit on higher sales, helped by growing demand for its artificial intelligence offerings. The stock rose 4.5% to $15.53 in ...

UiPath’s third quarter performance was marked by stronger-than-expected revenue and profitability, with the market responding favorably to both top-line growth and improved margins. Management ...

Automation software company UiPath (NYSE:PATH) in Q3 CY2025, with sales up 15.9% year on year to $411.1 million. The company ...

Extracellular vesicles (EVs) have rapidly emerged as one of the most promising frontiers in modern biology. These nano-sized messengers mediate communication between cells, tissues, and organs, ...